Identification of Novel Interactions Between Domains of Myosin Binding Protein-C That Are Modulated by Hypertrophic Cardiomyopathy Missense Mutations
暂无分享,去创建一个
H. Watkins | J. Moolman-Smook | V. Corfield | W. D. de Lange | E. Flashman | C. Redwood | Hugh Watkins | Johanna Moolman-Smook | Emily Flashman | Willem de Lange | Zhili Li | Valerie Corfield | Charles Redwood | Zhi-li Li
[1] F. E. Weber,et al. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif , 1993, The Journal of cell biology.
[2] J. Squire,et al. Myosin rod-packing schemes in vertebrate muscle thick filaments. , 1998, Journal of structural biology.
[3] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[4] T. Hewett,et al. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. , 1999, Circulation research.
[5] H. Watkins,et al. Altered Regulatory Properties of Human Cardiac Troponin I Mutants That Cause Hypertrophic Cardiomyopathy* , 2000, The Journal of Biological Chemistry.
[6] M. Gautel,et al. The C-protein (myosin binding protein C) family: regulators of contraction and sarcomere formation? , 1999, Reviews of physiology, biochemistry and pharmacology.
[7] J. Seidman,et al. Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[8] M. Gautel,et al. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. , 1999, Journal of molecular biology.
[9] R. Jeremy,et al. Counselling issues in familial hypertrophic cardiomyopathy. , 1998, Journal of medical genetics.
[10] V. Berezin,et al. The First Immunoglobulin-like Neural Cell Adhesion Molecule (NCAM) Domain Is Involved in Double-reciprocal Interaction with the Second Immunoglobulin-like NCAM Domain and in Heparin Binding* , 1997, The Journal of Biological Chemistry.
[11] M. Gautel,et al. Phosphorylation switches specific for the cardiac isoform of myosin binding protein‐C: a modulator of cardiac contraction? , 1995, The EMBO journal.
[12] S. Winegrad,et al. Relation between crossbridge structure and actomyosin ATPase activity in rat heart. , 1998, Circulation research.
[13] H. Watkins,et al. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.
[14] F. E. Weber,et al. Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment. , 1993, European journal of biochemistry.
[15] R. Starr,et al. The interaction of C-protein with heavy meromyosin and subfragment-2. , 1978, The Biochemical journal.
[16] B. Hainque,et al. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. , 1999, Journal of molecular biology.
[17] J. Moolman-Smook,et al. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. , 1999, American journal of human genetics.
[18] I Kulikovskaya,et al. Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. , 2001, Biophysical journal.
[19] D. Vučković,et al. Familial Hypertrophic Cardiomyopathy , 2007, Herz Kardiovaskuläre Erkrankungen.
[20] H. C. Hartzell,et al. Structure of C protein purified from cardiac muscle , 1985, The Journal of cell biology.
[21] J. Beckmann,et al. Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[22] M. Davies,et al. Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C* , 2001, The Journal of Biological Chemistry.
[23] J. Cohen,et al. Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle. , 1999, Journal of cell science.
[24] M. Way,et al. Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis , 1989, The Journal of cell biology.
[25] M. Gautel,et al. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. , 1996, European journal of biochemistry.
[26] R. Starr,et al. A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization. , 1973, Journal of molecular biology.
[27] R. Starr,et al. The structure of C-protein and X-protein molecules and a polymer of X-protein. , 1985, Journal of molecular biology.
[28] A. Pastore,et al. Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set. , 1995, Structure.
[29] G. Offer. C-Protein and the Periodicity in the Thick Filaments of Vertebrate Skeletal Muscle , 1973 .
[30] J. Moolman-Smook,et al. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. , 1998, Journal of medical genetics.
[31] R. Starr,et al. Interaction of C-protein with myosin, myosin rod and light meromyosin. , 1975, Journal of molecular biology.
[32] S. Winegrad. Cardiac myosin binding protein C. , 1999, Circulation research.
[33] J. Seidman,et al. Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly , 2002, Circulation.
[34] R. Jeremy,et al. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. , 1998, Journal of medical genetics.
[35] H. C. Hartzell,et al. Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. , 1982, The Journal of biological chemistry.
[36] J. Trinick,et al. Titin and the sarcomere symmetry paradox. , 2001, Journal of molecular biology.
[37] Christine E. Seidman,et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.
[38] J. Tardiff,et al. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice , 2001, The Journal of physiology.
[39] M. Gautel,et al. Letter to the Editor: Sequence specific resonance assignment of the central domain of cardiac Myosin Binding Protein C (MyBP-C) , 2002, Journal of biomolecular NMR.
[40] M. Gautel,et al. cAPK‐phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin‐S2 in an on‐off fashion , 1999, FEBS letters.